Achilles Therapeutics Plc Stock Shares Outstanding
| ACHLDelisted Stock | USD 1.48 0.00 0.00% |
Fundamental analysis of Achilles Therapeutics allows traders to better anticipate movements in Achilles Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Achilles |
Achilles Therapeutics PLC Company Shares Outstanding Analysis
Achilles Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Achilles Therapeutics Shares Outstanding | 41.1 M |
Most of Achilles Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achilles Therapeutics PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Achilles Therapeutics PLC has 41.1 M of shares currently outstending. This is 77.23% lower than that of the Biotechnology sector and 61.54% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 92.81% higher than that of the company.
Achilles Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achilles Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Achilles Therapeutics could also be used in its relative valuation, which is a method of valuing Achilles Therapeutics by comparing valuation metrics of similar companies.Achilles Therapeutics is currently under evaluation in shares outstanding category among its peers.
Achilles Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | (19.21 M) | |||
| Shares Outstanding | 41.1 M | |||
| Shares Owned By Insiders | 6.28 % | |||
| Shares Owned By Institutions | 83.09 % | |||
| Number Of Shares Shorted | 797.85 K | |||
| Price To Earning | 0.49 X | |||
| Price To Book | 0.59 X | |||
| EBITDA | (70.44 M) | |||
| Net Income | (69.94 M) | |||
| Cash And Equivalents | 201.6 M | |||
| Cash Per Share | 4.94 X | |||
| Total Debt | 4.62 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 11.45 X | |||
| Book Value Per Share | 2.51 X | |||
| Cash Flow From Operations | (48.45 M) | |||
| Short Ratio | 0.23 X | |||
| Earnings Per Share | (1.66) X | |||
| Price To Earnings To Growth | (0.31) X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 204 | |||
| Beta | 1.25 | |||
| Market Capitalization | 63.22 M | |||
| Total Asset | 161.46 M | |||
| Retained Earnings | (259.95 M) | |||
| Working Capital | 128.64 M | |||
| Net Asset | 161.46 M |
About Achilles Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achilles Therapeutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achilles Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achilles Therapeutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |